PASSAGE BIO INC's ticker is PASG and the CUSIP is 702712100. A total of 55 filers reported holding PASSAGE BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $182 | -10.8% | 276 | +27.2% | 0.00% | – |
Q2 2023 | $204 | -86.7% | 217 | -86.5% | 0.00% | – |
Q1 2023 | $1,539 | +53.9% | 1,607 | +161.3% | 0.00% | – |
Q4 2022 | $1,000 | – | 615 | +615.1% | 0.00% | – |
Q3 2022 | $0 | – | 86 | -51.7% | 0.00% | – |
Q2 2022 | $0 | -100.0% | 178 | -45.4% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 326 | +11.3% | 0.00% | – |
Q4 2021 | $2,000 | 0.0% | 293 | +17.2% | 0.00% | – |
Q3 2021 | $2,000 | -33.3% | 250 | +4.2% | 0.00% | – |
Q2 2021 | $3,000 | -25.0% | 240 | 0.0% | 0.00% | – |
Q1 2021 | $4,000 | – | 240 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,497,922 | $1,648,629 | 2.12% |
Versant Venture Management, LLC | 4,959,769 | $3,263,528 | 1.74% |
BML Capital Management, LLC | 2,058,767 | $1,354,669 | 1.24% |
Acuitas Investments, LLC | 418,161 | $275,150 | 0.16% |
Orbimed Advisors | 10,124,576 | $6,661,971 | 0.14% |
Lynx1 Capital Management LP | 190,124 | $125,102 | 0.08% |
Frazier Life Sciences Management, L.P. | 1,758,219 | $1,156,908 | 0.08% |
TANG CAPITAL MANAGEMENT LLC | 400,000 | $263,200 | 0.04% |
Marquette Asset Management, LLC | 86,050 | $56,621 | 0.01% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 506,600 | $333,343 | 0.01% |